"This update was ahead of my expectations ..." Indeed....

"This update was ahead of my expectations ..."

Indeed.
Travelling a darn sight lot better than might have otherwise been the case.

They say that you only really get to know the true pedigree of a company once you've seen how it performs through some really bad times.

This one looks like it is passing muster very very well.

A $12m company, with just $1.2m in net debt and limited ongoing capital requirements, generating more than $3m pa in EBITDA on Revenue of $25m pa....I suspect it will be a lot larger than a $12m company if it continues growing as it has done:

Revenue (growth on pcp):
FY2017: $9.9m
FY2018: $12.5m (27%)
FY2019: $22.0m (76%)
FY2020: $25.0m (14%... Covid-affected)

(And that growth hasn't come about by thumping the share capital account; since listing, Issued Number of Shares has increased by 57% while Revenue and EBITDA have increased by 153% and 180%, respectively, so the growth has been accretive)

Impossible stock to buy, however.
Basically trades by appointment.

.